<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-08-01" modified="2017-12-20" version="194">
<accession>P22309</accession>
<accession>A6NJC3</accession>
<accession>B8K286</accession>
<name>UD11_HUMAN</name>
<protein>
<recommendedName>
<fullName>UDP-glucuronosyltransferase 1-1</fullName>
<shortName>UDPGT 1-1</shortName>
<shortName>UGT1*1</shortName>
<shortName>UGT1-01</shortName>
<shortName>UGT1.1</shortName>
<ecNumber>2.4.1.17</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Bilirubin-specific UDPGT isozyme 1</fullName>
<shortName>hUG-BR1</shortName>
</alternativeName>
<alternativeName>
<fullName>UDP-glucuronosyltransferase 1-A</fullName>
<shortName>UGT-1A</shortName>
<shortName>UGT1A</shortName>
</alternativeName>
<alternativeName>
<fullName>UDP-glucuronosyltransferase 1A1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">UGT1A1</name>
<name type="synonym">GNT1</name>
<name type="synonym">UGT1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="1043" last="1047">
<title>Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells.</title>
<authorList>
<person name="Ritter J.K."/>
<person name="Crawford J.M."/>
<person name="Owens I.S."/>
</authorList>
<dbReference type="PubMed" id="1898728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="3257" last="3261">
<title>A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.</title>
<authorList>
<person name="Ritter J.K."/>
<person name="Chen F."/>
<person name="Sheen Y.Y."/>
<person name="Tran H.M."/>
<person name="Kimura S."/>
<person name="Yeatman M.T."/>
<person name="Owens I.S."/>
</authorList>
<dbReference type="PubMed" id="1339448"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Pharmacogenetics" volume="11" first="357" last="368">
<title>Thirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.</title>
<authorList>
<person name="Gong Q.H."/>
<person name="Cho J.W."/>
<person name="Huang T."/>
<person name="Potter C."/>
<person name="Gholami N."/>
<person name="Basu N.K."/>
<person name="Kubota S."/>
<person name="Carvalho S."/>
<person name="Pennington M.W."/>
<person name="Owens I.S."/>
<person name="Popescu N.C."/>
</authorList>
<dbReference type="PubMed" id="11434514"/>
<dbReference type="DOI" id="10.1097/00008571-200106000-00011"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2006-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Guillemette C."/>
<person name="Levesque E."/>
<person name="Girard H."/>
<person name="Bernard O."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Hepatol. Res." volume="9" first="152" last="163">
<title>Analysis of the promoter of human bilirubin UDP-glucuronosyltransferase gene (UGT1*1) in relevance to Gilbert's syndrome.</title>
<authorList>
<person name="Ueyama H."/>
<person name="Koiwai O."/>
<person name="Soeda Y."/>
<person name="Sato H."/>
<person name="Satoh Y."/>
<person name="Ohkubo I."/>
<person name="Doida Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-50</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="4456" last="4469">
<title>A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins.</title>
<authorList>
<person name="Meunier L."/>
<person name="Usherwood Y.-K."/>
<person name="Chung K.T."/>
<person name="Hendershot L.M."/>
</authorList>
<dbReference type="PubMed" id="12475965"/>
<dbReference type="DOI" id="10.1091/mbc.E02-05-0311"/>
</citation>
<scope>COMPONENT OF A CHAPERONE COMPLEX</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Hepatology" volume="45" first="128" last="138">
<title>Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus.</title>
<authorList>
<person name="Levesque E."/>
<person name="Girard H."/>
<person name="Journault K."/>
<person name="Lepine J."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="17187418"/>
<dbReference type="DOI" id="10.1002/hep.21464"/>
</citation>
<scope>ALTERNATIVE SPLICING</scope>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Pharmacogenet. Genomics" volume="17" first="1017" last="1029">
<title>Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.</title>
<authorList>
<person name="Udomuksorn W."/>
<person name="Elliot D.J."/>
<person name="Lewis B.C."/>
<person name="Mackenzie P.I."/>
<person name="Yoovathaworn K."/>
<person name="Miners J.O."/>
</authorList>
<dbReference type="PubMed" id="18004206"/>
<dbReference type="DOI" id="10.1097/FPC.0b013e328256b1b6"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>KINETIC PARAMETERS</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>CHARACTERIZATION OF VARIANTS CN2 ARG-71; LEU-83; GLN-229 AND ASP-486</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Pharmacogenet. Genomics" volume="17" first="1077" last="1089">
<title>Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity.</title>
<authorList>
<person name="Girard H."/>
<person name="Levesque E."/>
<person name="Bellemare J."/>
<person name="Journault K."/>
<person name="Caillier B."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="18004212"/>
<dbReference type="DOI" id="10.1097/FPC.0b013e3282f1f118"/>
</citation>
<scope>ALTERNATIVE SPLICING</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Mol. Pharm." volume="6" first="1466" last="1482">
<title>Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones.</title>
<authorList>
<person name="Tang L."/>
<person name="Singh R."/>
<person name="Liu Z."/>
<person name="Hu M."/>
</authorList>
<dbReference type="PubMed" id="19545173"/>
<dbReference type="DOI" id="10.1021/mp8002557"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="52" last="59">
<title>Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.</title>
<authorList>
<person name="Sneitz N."/>
<person name="Bakker C.T."/>
<person name="de Knegt R.J."/>
<person name="Halley D.J."/>
<person name="Finel M."/>
<person name="Bosma P.J."/>
</authorList>
<dbReference type="PubMed" id="19830808"/>
<dbReference type="DOI" id="10.1002/humu.21133"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>VARIANT CN1 THR-402</scope>
<scope>VARIANTS CN2 ARG-15; ARG-71; PHE-191; TRP-209; TRP-336; HIS-387; PRO-443 AND ASP-486</scope>
<scope>CHARACTERIZATION OF VARIANT CN1 THR-402</scope>
<scope>CHARACTERIZATION OF VARIANTS CN2 ARG-71; GLN-175; PHE-191; TRP-209; ARG-331; TRP-336; HIS-387; VAL-395 AND PRO-443</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="2700" last="2710">
<title>Genome-wide association meta-analysis for total serum bilirubin levels.</title>
<authorList>
<person name="Johnson A.D."/>
<person name="Kavousi M."/>
<person name="Smith A.V."/>
<person name="Chen M.H."/>
<person name="Dehghan A."/>
<person name="Aspelund T."/>
<person name="Lin J.P."/>
<person name="van Duijn C.M."/>
<person name="Harris T.B."/>
<person name="Cupples L.A."/>
<person name="Uitterlinden A.G."/>
<person name="Launer L."/>
<person name="Hofman A."/>
<person name="Rivadeneira F."/>
<person name="Stricker B."/>
<person name="Yang Q."/>
<person name="O'Donnell C.J."/>
<person name="Gudnason V."/>
<person name="Witteman J.C."/>
</authorList>
<dbReference type="PubMed" id="19414484"/>
<dbReference type="DOI" id="10.1093/hmg/ddp202"/>
</citation>
<scope>INVOLVEMENT IN BILIQTL1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-102</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="Drug Metab. Dispos." volume="38" first="1785" last="1789">
<title>Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.</title>
<authorList>
<person name="Bellemare J."/>
<person name="Rouleau M."/>
<person name="Girard H."/>
<person name="Harvey M."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="20610558"/>
<dbReference type="DOI" id="10.1124/dmd.110.034835"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="1992" name="FASEB J." volume="6" first="2859" last="2863">
<title>Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.</title>
<authorList>
<person name="Bosma P.J."/>
<person name="Chowdhury J.R."/>
<person name="Huang T.-J."/>
<person name="Lahiri P."/>
<person name="Elferink R.P.J.O."/>
<person name="van Es H.H.G."/>
<person name="Lederstein M."/>
<person name="Whitington P.F."/>
<person name="Jansen P.L.M."/>
<person name="Chowdhury N.R."/>
</authorList>
<dbReference type="PubMed" id="1634050"/>
</citation>
<scope>VARIANT CN1 PHE-375</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="197" first="1239" last="1244">
<title>Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.</title>
<authorList>
<person name="Aono S."/>
<person name="Yamada Y."/>
<person name="Keino H."/>
<person name="Hanada N."/>
<person name="Nakagawa T."/>
<person name="Sasaoka Y."/>
<person name="Yazawa T."/>
<person name="Sato H."/>
<person name="Koiwai O."/>
</authorList>
<dbReference type="PubMed" id="8280139"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.2610"/>
</citation>
<scope>VARIANTS CN2 ARG-71 AND ASP-486</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1993" name="Genomics" volume="18" first="171" last="173">
<title>Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.</title>
<authorList>
<person name="Moghrabi N."/>
<person name="Clarke D.J."/>
<person name="Boxer M."/>
<person name="Burchell B."/>
</authorList>
<dbReference type="PubMed" id="8276413"/>
<dbReference type="DOI" id="10.1006/geno.1993.1451"/>
</citation>
<scope>VARIANT CN2 ARG-331</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="23573" last="23579">
<title>A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.</title>
<authorList>
<person name="Ritter J.K."/>
<person name="Yeatman M.T."/>
<person name="Kaiser C."/>
<person name="Gridelli B."/>
<person name="Owens I.S."/>
</authorList>
<dbReference type="PubMed" id="8226884"/>
</citation>
<scope>VARIANT CN1 PHE-170 DEL</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1994" name="Hum. Genet." volume="94" first="693" last="697">
<title>Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.</title>
<authorList>
<person name="Labrune P."/>
<person name="Myara A."/>
<person name="Hadchouel M."/>
<person name="Ronchi F."/>
<person name="Bernard O."/>
<person name="Trivin F."/>
<person name="Roy Chowdhury N."/>
<person name="Roy Chowdhury J."/>
<person name="Munnich A."/>
<person name="Odievre M."/>
</authorList>
<dbReference type="PubMed" id="7989045"/>
<dbReference type="DOI" id="10.1007/BF00206965"/>
</citation>
<scope>VARIANTS CN1 VAL-292; GLU-308; ARG-357; THR-368; ARG-381; PRO-401 AND GLU-428</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="93" first="564" last="570">
<title>Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.</title>
<authorList>
<person name="Erps L.T."/>
<person name="Ritter J.K."/>
<person name="Hersh J.H."/>
<person name="Blossom D."/>
<person name="Martin N.C."/>
<person name="Owens I.S."/>
</authorList>
<dbReference type="PubMed" id="7906695"/>
<dbReference type="DOI" id="10.1172/JCI117008"/>
</citation>
<scope>VARIANTS CN1 GLU-308 AND PHE-375</scope>
<scope>CHARACTERIZATION OF VARIANTS CN1 GLU-308 AND PHE-375</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="94" first="2385" last="2391">
<title>Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.</title>
<authorList>
<person name="Seppen J."/>
<person name="Bosma P.J."/>
<person name="Goldhoorn B.G."/>
<person name="Bakker C.T.M."/>
<person name="Roy Chowdhury J."/>
<person name="Roy Chowdhury N."/>
<person name="Jansen P.L.M."/>
<person name="Oude Elferink R.P.J."/>
</authorList>
<dbReference type="PubMed" id="7989595"/>
<dbReference type="DOI" id="10.1172/JCI117604"/>
</citation>
<scope>VARIANTS CN1 PHE-170 DEL; ARG-177; ARG-276 AND PHE-375</scope>
<scope>VARIANTS CN2 GLN-175 AND TRP-209</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1995" name="Lancet" volume="345" first="958" last="959">
<title>Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.</title>
<authorList>
<person name="Aono S."/>
<person name="Adachi Y."/>
<person name="Uyama E."/>
<person name="Yamada Y."/>
<person name="Keino H."/>
<person name="Nanno T."/>
<person name="Koiwai O."/>
<person name="Sato H."/>
</authorList>
<dbReference type="PubMed" id="7715297"/>
<dbReference type="DOI" id="10.1016/S0140-6736(95)90702-5"/>
</citation>
<scope>VARIANTS GILBS ARG-71; GLN-229 AND GLY-367</scope>
<source>
<tissue>Liver</tissue>
<tissue>Peripheral blood leukocyte</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="1996" name="FEBS Lett." volume="390" first="294" last="298">
<title>A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II.</title>
<authorList>
<person name="Seppen J."/>
<person name="Steenken E."/>
<person name="Lindhout D."/>
<person name="Bosma P.J."/>
<person name="Oude Elferink R.P.J."/>
</authorList>
<dbReference type="PubMed" id="8706880"/>
<dbReference type="DOI" id="10.1016/0014-5793(96)00677-1"/>
</citation>
<scope>VARIANT CN2 ARG-15</scope>
<scope>CHARACTERIZATION OF VARIANT CN2 ARG-15</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1998" name="Biochim. Biophys. Acta" volume="1407" first="40" last="50">
<title>Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.</title>
<authorList>
<person name="Ciotti M."/>
<person name="Chen F."/>
<person name="Rubaltelli F.F."/>
<person name="Owens I.S."/>
</authorList>
<dbReference type="PubMed" id="9639672"/>
<dbReference type="DOI" id="10.1016/S0925-4439(98)00030-1"/>
</citation>
<scope>VARIANT CN2 THR-294</scope>
<scope>CHARACTERIZATION OF VARIANT CN2 THR-294</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1998" name="J. Hum. Genet." volume="43" first="111" last="114">
<title>Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.</title>
<authorList>
<person name="Yamamoto K."/>
<person name="Soeda Y."/>
<person name="Kamisako T."/>
<person name="Hosaka H."/>
<person name="Fukano M."/>
<person name="Sato H."/>
<person name="Fujiyama Y."/>
<person name="Dachi Y."/>
<person name="Satoh Y."/>
<person name="Bamba T."/>
</authorList>
<dbReference type="PubMed" id="9621515"/>
<dbReference type="DOI" id="10.1007/s100380050050"/>
</citation>
<scope>VARIANTS CN2 ARG-71; TRP-209; GLN-229 AND ASP-486</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="J. Pediatr." volume="132" first="1045" last="1047">
<title>Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene.</title>
<authorList>
<person name="Maruo Y."/>
<person name="Sato H."/>
<person name="Yamano T."/>
<person name="Doida Y."/>
<person name="Shimada M."/>
</authorList>
<dbReference type="PubMed" id="9627603"/>
<dbReference type="DOI" id="10.1016/S0022-3476(98)70408-1"/>
</citation>
<scope>VARIANT GILBS ASP-486</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="16" first="297" last="306">
<title>Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.</title>
<authorList>
<person name="Kadakol A."/>
<person name="Ghosh S.S."/>
<person name="Sappal B.S."/>
<person name="Sharma G."/>
<person name="Chowdhury J.R."/>
<person name="Chowdhury N.R."/>
</authorList>
<dbReference type="PubMed" id="11013440"/>
<dbReference type="DOI" id="10.1002/1098-1004(200010)16:4&lt;297::AID-HUMU2>3.0.CO;2-Z"/>
</citation>
<scope>VARIANTS CN1 ASP-39; PHE-170 DEL; ARG-177; ARG-276; VAL-291; GLU-308; TRP-336; ARG-357; THR-368; PHE-375; ARG-381; SER-387; PRO-401 AND GLU-428</scope>
<scope>VARIANTS CN2 ARG-15; GLN-175; TRP-209; GLY-225 AND ARG-331</scope>
<scope>VARIANTS GILBS ARG-71; GLN-229; THR-294; GLY-367 AND ASP-486</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2000" name="Pediatrics" volume="106" first="E59" last="E59">
<title>Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene.</title>
<authorList>
<person name="Maruo Y."/>
<person name="Nishizawa K."/>
<person name="Sato H."/>
<person name="Sawa H."/>
<person name="Shimada M."/>
</authorList>
<dbReference type="PubMed" id="11061796"/>
<dbReference type="DOI" id="10.1542/peds.106.5.e59"/>
</citation>
<scope>VARIANTS HBLRTFN ARG-71 AND ASP-486</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2001" name="J. Med. Genet." volume="38" first="244" last="249">
<title>Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.</title>
<authorList>
<person name="Kadakol A."/>
<person name="Sappal B.S."/>
<person name="Ghosh S.S."/>
<person name="Lowenheim M."/>
<person name="Chowdhury A."/>
<person name="Chowdhury S."/>
<person name="Santra A."/>
<person name="Arias I.M."/>
<person name="Chowdhury J.R."/>
<person name="Chowdhury N.R."/>
</authorList>
<dbReference type="PubMed" id="11370628"/>
<dbReference type="DOI" id="10.1136/jmg.38.4.244"/>
</citation>
<scope>VARIANT CN2 GLN-175</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="399" last="401">
<title>Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.</title>
<authorList>
<person name="Labrune P."/>
<person name="Myara A."/>
<person name="Chalas J."/>
<person name="Le Bihan B."/>
<person name="Capel L."/>
<person name="Francoual J."/>
</authorList>
<dbReference type="PubMed" id="12402338"/>
<dbReference type="DOI" id="10.1002/humu.10122"/>
</citation>
<scope>VARIANT CN2 ASP-400</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2002" name="Pediatr. Int." volume="44" first="427" last="432">
<title>Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome.</title>
<authorList>
<person name="Sutomo R."/>
<person name="Laosombat V."/>
<person name="Sadewa A.H."/>
<person name="Yokoyama N."/>
<person name="Nakamura H."/>
<person name="Matsuo M."/>
<person name="Nishio H."/>
</authorList>
<dbReference type="PubMed" id="12139570"/>
<dbReference type="DOI" id="10.1046/j.1442-200X.2002.t01-1-01577.x"/>
</citation>
<scope>VARIANT GILBS LEU-83</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="310" first="735" last="741">
<title>Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II.</title>
<authorList>
<person name="Ohnishi A."/>
<person name="Emi Y."/>
</authorList>
<dbReference type="PubMed" id="14550264"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.09.072"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT CN2 ARG-15</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="25" first="325" last="325">
<title>Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.</title>
<authorList>
<person name="Servedio V."/>
<person name="d'Apolito M."/>
<person name="Maiorano N."/>
<person name="Minuti B."/>
<person name="Torricelli F."/>
<person name="Ronchi F."/>
<person name="Zancan L."/>
<person name="Perrotta S."/>
<person name="Vajro P."/>
<person name="Boschetto L."/>
<person name="Iolascon A."/>
</authorList>
<dbReference type="PubMed" id="15712364"/>
<dbReference type="DOI" id="10.1002/humu.9322"/>
</citation>
<scope>VARIANTS CN1 GLN-336; ARG-357; PHE-375; SER-387 AND VAL-395</scope>
<scope>VARIANTS CN2 GLN-34; PHE-170 DEL; TRP-209; GLY-225; LEU-336; TRP-336; ARG-354; CYS-403 AND ASP-478</scope>
<scope>VARIANTS CN1/CN2 VAL-377 AND ARG-461</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Haematologica" volume="92" first="133" last="134">
<title>Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia.</title>
<authorList>
<person name="D'Apolito M."/>
<person name="Marrone A."/>
<person name="Servedio V."/>
<person name="Vajro P."/>
<person name="De Falco L."/>
<person name="Iolascon A."/>
</authorList>
<dbReference type="PubMed" id="17229650"/>
<dbReference type="DOI" id="10.3324/haematol.10585"/>
</citation>
<scope>VARIANT CN1 PHE-171 DEL</scope>
<scope>VARIANTS CN2 TYR-279; ARG-354; VAL-370; VAL-395; PRO-443 AND ARG-461</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="Ann. Hum. Genet." volume="77" first="482" last="487">
<title>UGT1A1 gene mutations in Pakistani children suffering from inherited nonhemolytic unconjugated hyperbilirubinemias.</title>
<authorList>
<person name="Khan S."/>
<person name="Irfan M."/>
<person name="Sher G."/>
<person name="Zubaida B."/>
<person name="Alvi M.A."/>
<person name="Yasinzai M."/>
<person name="Naeem M."/>
</authorList>
<dbReference type="PubMed" id="23992562"/>
<dbReference type="DOI" id="10.1111/ahg.12039"/>
</citation>
<scope>VARIANT CN1 ASN-36</scope>
<scope>VARIANT CN2 CYS-230</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="Clin. Biochem." volume="46" first="170" last="172">
<title>Identification of a novel mutation in UDP-glucuronosyltransferase (UGT1A1) gene in a child with neonatal unconjugated hyperbilirubinemia.</title>
<authorList>
<person name="Minucci A."/>
<person name="Canu G."/>
<person name="Gentile L."/>
<person name="Cimino V."/>
<person name="Giardina B."/>
<person name="Zuppi C."/>
<person name="Capoluongo E."/>
</authorList>
<dbReference type="PubMed" id="23099197"/>
<dbReference type="DOI" id="10.1016/j.clinbiochem.2012.10.007"/>
</citation>
<scope>VARIANTS CN2 PHE-170 DEL AND CYS-367</scope>
</reference>
<comment type="function">
<text evidence="13 17 18">UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.</text>
</comment>
<comment type="catalytic activity">
<text evidence="13 14">UDP-glucuronate + acceptor = UDP + acceptor beta-D-glucuronoside.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="13">0.26 uM for bilirubin</KM>
<Vmax evidence="13">1080 pmol/min/mg enzyme with bilirubin as substrate</Vmax>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="11 19">Isoform 1 interacts with isoform 2/i2 suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2. Isoform 1 also interacts with respective i2 isoforms of UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9 and UGT1A10. Part of a large chaperone multiprotein complex comprising DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1, UGT1A1 and very small amounts of ERP29, but not, or at very low levels, CALR nor CANX.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="11">Microsome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Endoplasmic reticulum membrane</location>
<topology evidence="34">Single-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="11">Microsome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Endoplasmic reticulum</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P22309-1</id>
<name>1</name>
<name>i1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P22309-2</id>
<name>2</name>
<name>i2</name>
<name>UGT1A1s</name>
<sequence type="described" ref="VSP_053958"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7 11 14">Isoform 1 and isoform 2 are expressed in liver, colon and small intestine. Isoform 2 but not isoform 1 is expressed in kidney. Isoform 1 and isoform 2 are not expressed in esophagus. Not expressed in skin.</text>
</comment>
<comment type="polymorphism">
<text evidence="16">Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1 (BILIQTL1) [MIM:601816]. Variation in serum bilirubin is associated with altered cardiovascular disease risk and drug metabolism.</text>
</comment>
<comment type="disease" evidence="2 5 22 31">
<disease id="DI-01659">
<name>Gilbert syndrome</name>
<acronym>GILBS</acronym>
<description>Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints.</description>
<dbReference type="MIM" id="143500"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="3">
<disease id="DI-02379">
<name>Transient familial neonatal hyperbilirubinemia</name>
<acronym>HBLRTFN</acronym>
<description>A condition characterized by excessive concentration of bilirubin in the blood, which may lead to jaundice. Breast milk jaundice is a common problem in nursing infants.</description>
<dbReference type="MIM" id="237900"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry. The defect has been ascribed to various breast milk substances, but the component or combination of components that is responsible remains unclear. Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk. One or more components in the milk may trigger the jaundice in infants who have such mutations. Mutations are identical to those detected in patients with Gilbert syndrome, a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia.</text>
</comment>
<comment type="disease" evidence="2 9 10 12 18 21 23 24 25 26">
<disease id="DI-01449">
<name>Crigler-Najjar syndrome 1</name>
<acronym>CN1</acronym>
<description>Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life. CN1 inheritance is autosomal recessive.</description>
<dbReference type="MIM" id="218800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="2 4 6 8 9 12 13 18 20 21 25 27 28 29 30 32">
<disease id="DI-01450">
<name>Crigler-Najjar syndrome 2</name>
<acronym>CN2</acronym>
<description>Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage. Phenobarbital, which induces the partially deficient glucuronyl transferase, can diminish the jaundice. CN2 inheritance is autosomal dominant.</description>
<dbReference type="MIM" id="606785"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>The gene is part of the UGT1A complex locus which displays alternative use of promoters, first exons and terminal exons. The locus is defined by 13 first exons, which are alternatively spliced to 3 other common exons and 2 alternative terminal exons 5. From the 27 possible mRNA isoforms, 9 produce functionally active polypeptides (UGT1A1, 1A3, 1A4, 1A5, 1A6, 1A7, 1A8, 1A9 and 1A10) called isoforms 1 (i1). Use of an alternative exon 5 (5b) as terminal exon is leading to 9 additional alternatively spliced products termed isoforms i2 and which lack transferase activity.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the UDP-glycosyltransferase family.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAA61247" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAF03522" version="2"/>
</conflict>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Glucuronosyltransferase"/>
<text>Glucuronosyltransferase entry</text>
</comment>
<dbReference type="EC" id="2.4.1.17"/>
<dbReference type="EMBL" id="M57899">
<property type="protein sequence ID" value="AAA63195.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M84124">
<property type="protein sequence ID" value="AAA61247.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M84122">
<property type="protein sequence ID" value="AAA61247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M84123">
<property type="protein sequence ID" value="AAA61247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M84125">
<property type="protein sequence ID" value="AAA61248.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ364247">
<property type="protein sequence ID" value="ABC96771.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF297093">
<property type="protein sequence ID" value="AAG30424.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006985">
<property type="protein sequence ID" value="AAF03522.2"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D87674">
<property type="protein sequence ID" value="BAA25600.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2510.1">
<molecule id="P22309-1"/>
</dbReference>
<dbReference type="PIR" id="A39092">
<property type="entry name" value="A39092"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000454.1">
<molecule id="P22309-1"/>
<property type="nucleotide sequence ID" value="NM_000463.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.554822"/>
<dbReference type="ProteinModelPortal" id="P22309"/>
<dbReference type="BioGrid" id="120087">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="ELM" id="P22309"/>
<dbReference type="IntAct" id="P22309">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000304845"/>
<dbReference type="BindingDB" id="P22309"/>
<dbReference type="ChEMBL" id="CHEMBL1287617"/>
<dbReference type="DrugBank" id="DB01048">
<property type="generic name" value="Abacavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00316">
<property type="generic name" value="Acetaminophen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00173">
<property type="generic name" value="Adenine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01076">
<property type="generic name" value="Atorvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB06626">
<property type="generic name" value="Axitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00586">
<property type="generic name" value="Diclofenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB08930">
<property type="generic name" value="Dolutegravir"/>
</dbReference>
<dbReference type="DrugBank" id="DB06210">
<property type="generic name" value="Eltrombopag"/>
</dbReference>
<dbReference type="DrugBank" id="DB00530">
<property type="generic name" value="Erlotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00783">
<property type="generic name" value="Estradiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00773">
<property type="generic name" value="Etoposide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00973">
<property type="generic name" value="Ezetimibe"/>
</dbReference>
<dbReference type="DrugBank" id="DB04953">
<property type="generic name" value="Ezogabine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01544">
<property type="generic name" value="Flunitrazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00712">
<property type="generic name" value="Flurbiprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01095">
<property type="generic name" value="Fluvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB06741">
<property type="generic name" value="Gavestinel"/>
</dbReference>
<dbReference type="DrugBank" id="DB01050">
<property type="generic name" value="Ibuprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB05039">
<property type="generic name" value="Indacaterol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00328">
<property type="generic name" value="Indomethacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00762">
<property type="generic name" value="Irinotecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00678">
<property type="generic name" value="Losartan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00227">
<property type="generic name" value="Lovastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00295">
<property type="generic name" value="Morphine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00688">
<property type="generic name" value="Mycophenolate mofetil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01024">
<property type="generic name" value="Mycophenolic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00704">
<property type="generic name" value="Naltrexone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00788">
<property type="generic name" value="Naproxen"/>
</dbReference>
<dbReference type="DrugBank" id="DB04868">
<property type="generic name" value="Nilotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06589">
<property type="generic name" value="Pazopanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00818">
<property type="generic name" value="Propofol"/>
</dbReference>
<dbReference type="DrugBank" id="DB06817">
<property type="generic name" value="Raltegravir"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01045">
<property type="generic name" value="Rifampicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00641">
<property type="generic name" value="Simvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00870">
<property type="generic name" value="Suprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01420">
<property type="generic name" value="Testosterone Propionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00197">
<property type="generic name" value="Troglitazone"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000001697"/>
<dbReference type="CAZy" id="GT1">
<property type="family name" value="Glycosyltransferase Family 1"/>
</dbReference>
<dbReference type="iPTMnet" id="P22309"/>
<dbReference type="PhosphoSitePlus" id="P22309"/>
<dbReference type="BioMuta" id="UGT1A1"/>
<dbReference type="DMDM" id="136729"/>
<dbReference type="PaxDb" id="P22309"/>
<dbReference type="PeptideAtlas" id="P22309"/>
<dbReference type="PRIDE" id="P22309"/>
<dbReference type="DNASU" id="54658"/>
<dbReference type="Ensembl" id="ENST00000305208">
<molecule id="P22309-1"/>
<property type="protein sequence ID" value="ENSP00000304845"/>
<property type="gene ID" value="ENSG00000241635"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000360418">
<molecule id="P22309-2"/>
<property type="protein sequence ID" value="ENSP00000353593"/>
<property type="gene ID" value="ENSG00000241635"/>
</dbReference>
<dbReference type="GeneID" id="54658"/>
<dbReference type="KEGG" id="hsa:54658"/>
<dbReference type="CTD" id="54658"/>
<dbReference type="DisGeNET" id="54658"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000241635.7"/>
<dbReference type="GeneCards" id="UGT1A1"/>
<dbReference type="HGNC" id="HGNC:12530">
<property type="gene designation" value="UGT1A1"/>
</dbReference>
<dbReference type="MalaCards" id="UGT1A1"/>
<dbReference type="MIM" id="143500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="191740">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="218800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="237900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601816">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606785">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P22309"/>
<dbReference type="OpenTargets" id="ENSG00000241635"/>
<dbReference type="Orphanet" id="79234">
<property type="disease" value="Crigler-Najjar syndrome type 1"/>
</dbReference>
<dbReference type="Orphanet" id="79235">
<property type="disease" value="Crigler-Najjar syndrome type 2"/>
</dbReference>
<dbReference type="Orphanet" id="357">
<property type="disease" value="Gilbert syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="240885">
<property type="disease" value="Irinotecan toxicity"/>
</dbReference>
<dbReference type="Orphanet" id="240905">
<property type="disease" value="Raltegravir toxicity"/>
</dbReference>
<dbReference type="Orphanet" id="2312">
<property type="disease" value="Transient familial neonatal hyperbilirubinemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37181"/>
<dbReference type="PharmGKB" id="PA420"/>
<dbReference type="eggNOG" id="KOG1192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG1819">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118949"/>
<dbReference type="HOGENOM" id="HOG000220832"/>
<dbReference type="HOVERGEN" id="HBG004033"/>
<dbReference type="InParanoid" id="P22309"/>
<dbReference type="KO" id="K00699"/>
<dbReference type="OMA" id="ESHFRRM"/>
<dbReference type="OrthoDB" id="EOG091G06JC"/>
<dbReference type="PhylomeDB" id="P22309"/>
<dbReference type="TreeFam" id="TF315472"/>
<dbReference type="BRENDA" id="2.4.1.17">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="2.4.1.95">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-156588">
<property type="pathway name" value="Glucuronidation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-189483">
<property type="pathway name" value="Heme degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5579002">
<property type="pathway name" value="Defective UGT1A1 causes hyperbilirubinemia"/>
</dbReference>
<dbReference type="SABIO-RK" id="P22309"/>
<dbReference type="SIGNOR" id="P22309"/>
<dbReference type="GenomeRNAi" id="54658"/>
<dbReference type="PRO" id="PR:P22309"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000241635"/>
<dbReference type="CleanEx" id="HS_UGT1A1"/>
<dbReference type="ExpressionAtlas" id="P22309">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P22309">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070069">
<property type="term" value="C:cytochrome complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034663">
<property type="term" value="C:endoplasmic reticulum chaperone complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004857">
<property type="term" value="F:enzyme inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015020">
<property type="term" value="F:glucuronosyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001972">
<property type="term" value="F:retinoic acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005496">
<property type="term" value="F:steroid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006953">
<property type="term" value="P:acute-phase response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031100">
<property type="term" value="P:animal organ regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006789">
<property type="term" value="P:bilirubin conjugation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070980">
<property type="term" value="P:biphenyl catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0052695">
<property type="term" value="P:cellular glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071392">
<property type="term" value="P:cellular response to estradiol stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071361">
<property type="term" value="P:cellular response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071385">
<property type="term" value="P:cellular response to glucocorticoid stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007586">
<property type="term" value="P:digestion"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0017144">
<property type="term" value="P:drug metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008210">
<property type="term" value="P:estrogen metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0051552">
<property type="term" value="P:flavone metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052696">
<property type="term" value="P:flavonoid glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042167">
<property type="term" value="P:heme catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046483">
<property type="term" value="P:heterocycle metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001889">
<property type="term" value="P:liver development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001030">
<property type="term" value="P:negative regulation of cellular glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045922">
<property type="term" value="P:negative regulation of fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904224">
<property type="term" value="P:negative regulation of glucuronosyltransferase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045939">
<property type="term" value="P:negative regulation of steroid metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007584">
<property type="term" value="P:response to nutrient"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042594">
<property type="term" value="P:response to starvation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042573">
<property type="term" value="P:retinoic acid metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008202">
<property type="term" value="P:steroid metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052697">
<property type="term" value="P:xenobiotic glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR002213">
<property type="entry name" value="UDP_glucos_trans"/>
</dbReference>
<dbReference type="InterPro" id="IPR035595">
<property type="entry name" value="UDP_glycos_trans_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00201">
<property type="entry name" value="UDPGT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00375">
<property type="entry name" value="UDPGT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0328">Glycosyltransferase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="UDP-glucuronosyltransferase 1-1" id="PRO_0000036000">
<location>
<begin position="26"/>
<end position="533"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="491"/>
<end position="507"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="15">
<location>
<position position="102"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="295"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="347"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_053958" evidence="33">
<original>SYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH</original>
<variation>RKKQQSGRQM</variation>
<location>
<begin position="435"/>
<end position="533"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; mutant protein rapidly degraded by the proteasome owing to its mislocalization in the cell; dbSNP:rs111033541." id="VAR_019410" evidence="2 8 18 29">
<original>L</original>
<variation>R</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2." id="VAR_026134" evidence="9">
<original>P</original>
<variation>Q</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1." id="VAR_071402" evidence="21">
<original>D</original>
<variation>N</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551339." id="VAR_026135" evidence="2">
<original>H</original>
<variation>D</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2, GILBS and HBLRTFN; has significant residual bilirubin glucuronidation activity of about 25% to 50% of that of the wild-type protein; displays no change in biluribin affinity; dbSNP:rs4148323." id="VAR_009504" evidence="2 3 13 18 22 28 30">
<original>G</original>
<variation>R</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In GILBS; displays less than 10% of wild-type bilirubin glucuronidation activity; dbSNP:rs56059937." id="VAR_026136" evidence="5 13">
<original>F</original>
<variation>L</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1 and CN2; has nearly normal activity at pH 7.6 and is inactive at pH 6.4." id="VAR_007695" evidence="2 9 20 25 26">
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2." id="VAR_064955" evidence="12">
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; has low residual bilirubin glucuronidation activity of about 4.6% of that of the wild-type protein; dbSNP:rs72551341." id="VAR_019411" evidence="2 4 18 25">
<original>L</original>
<variation>Q</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551342." id="VAR_007697" evidence="2 25">
<original>C</original>
<variation>R</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; has low residual bilirubin glucuronidation activity of about 5.3% of that of the wild-type protein." id="VAR_064956" evidence="18">
<original>S</original>
<variation>F</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; has low residual bilirubin glucuronidation activity of about 2.9% of that of the wild-type protein; dbSNP:rs72551343." id="VAR_007698" evidence="2 9 18 25 30">
<original>R</original>
<variation>W</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; dbSNP:rs35003977." id="VAR_026137" evidence="2 9">
<original>V</original>
<variation>G</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2 and GILBS; displays 2-fold decrease in biluribin affinity and 61% of wild-type bilirubin glucuronidation activity; dbSNP:rs35350960." id="VAR_009505" evidence="2 13 22 30">
<original>P</original>
<variation>Q</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; dbSNP:rs754922685." id="VAR_071403" evidence="21">
<original>Y</original>
<variation>C</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551345." id="VAR_007699" evidence="2 25">
<original>G</original>
<variation>R</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; dbSNP:rs397978903." id="VAR_064957" evidence="12">
<original>N</original>
<variation>Y</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1." id="VAR_026138" evidence="2">
<original>E</original>
<variation>V</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1." id="VAR_007700" evidence="24">
<original>A</original>
<variation>V</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In GILBS and CN2; 40-55% normal activity; normal Km for bilirubin; when homozygous far less repressive and generates the mild Gilbert phenotype; dbSNP:rs72551347." id="VAR_026139" evidence="2 32">
<original>I</original>
<variation>T</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; no enzyme activity; dbSNP:rs62625011." id="VAR_007701" evidence="2 23 24">
<original>G</original>
<variation>E</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; has no residual bilirubin glucuronidation activity; dbSNP:rs72551348." id="VAR_007702" evidence="2 18 27">
<original>Q</original>
<variation>R</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1 and CN2." id="VAR_026140" evidence="9">
<original>R</original>
<variation>L</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs750453538." id="VAR_026141" evidence="9">
<original>R</original>
<variation>Q</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; has very low residual bilirubin glucuronidation activity of about 0.4% of that of the wild-type protein; dbSNP:rs139607673." id="VAR_026142" evidence="2 9 18">
<original>R</original>
<variation>W</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2." id="VAR_026143" evidence="9 12">
<original>W</original>
<variation>R</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551351." id="VAR_007703" evidence="2 9 24">
<original>Q</original>
<variation>R</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; dbSNP:rs55750087." id="VAR_071404" evidence="20">
<original>R</original>
<variation>C</variation>
<location>
<position position="367"/>
</location>
</feature>
<feature type="sequence variant" description="In GILBS; dbSNP:rs55750087." id="VAR_012283" evidence="2 22">
<original>R</original>
<variation>G</variation>
<location>
<position position="367"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551352." id="VAR_007704" evidence="2 24">
<original>A</original>
<variation>T</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; dbSNP:rs748989741." id="VAR_064958" evidence="12">
<original>I</original>
<variation>V</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; no enzyme activity; dbSNP:rs72551353." id="VAR_007705" evidence="2 9 10 23 25">
<original>S</original>
<variation>F</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1 and CN2." id="VAR_026144">
<original>H</original>
<variation>R</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1 and CN2." id="VAR_026145" evidence="9">
<original>G</original>
<variation>V</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551354." id="VAR_007706" evidence="2 24">
<original>S</original>
<variation>R</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; has no residual bilirubin glucuronidation activity." id="VAR_064959" evidence="18">
<original>P</original>
<variation>H</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs901936528." id="VAR_026146" evidence="2 9">
<original>P</original>
<variation>S</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; has no residual bilirubin glucuronidation activity; dbSNP:rs367897068." id="VAR_026147" evidence="9 12 18">
<original>G</original>
<variation>V</variation>
<location>
<position position="395"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; dbSNP:rs28934877." id="VAR_019412" evidence="6">
<original>N</original>
<variation>D</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551355." id="VAR_007707" evidence="2 24">
<original>A</original>
<variation>P</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; has no residual bilirubin glucuronidation activity; N-glycosylation does take place at this new additional site." id="VAR_064960" evidence="18">
<original>K</original>
<variation>T</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; dbSNP:rs778766461." id="VAR_026148" evidence="9">
<original>R</original>
<variation>C</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1; dbSNP:rs72551356." id="VAR_007708" evidence="2 24">
<original>K</original>
<variation>E</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2; has no residual bilirubin glucuronidation activity; dbSNP:rs758411577." id="VAR_064961" evidence="12 18">
<original>L</original>
<variation>P</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="sequence variant" description="In CN1 and CN2." id="VAR_026149" evidence="9 12">
<original>W</original>
<variation>R</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2." id="VAR_026150" evidence="9">
<original>A</original>
<variation>D</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence variant" description="In CN2, GILBS and HBLRTFN; displays less than 10% of wild-type bilirubin glucuronidation activity; dbSNP:rs34993780." id="VAR_007709" evidence="2 3 13 18 28 30 31">
<original>Y</original>
<variation>D</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1042709." id="VAR_025355">
<original>A</original>
<variation>P</variation>
<location>
<position position="511"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11013440"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11061796"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11370628"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12139570"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12402338"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1339448"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14550264"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15712364"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1634050"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17187418"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17229650"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18004206"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18004212"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19414484"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19545173"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19830808"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20610558"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23099197"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23992562"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7715297"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7906695"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7989045"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7989595"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8226884"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8276413"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8280139"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8706880"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9621515"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9627603"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9639672"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17187418"/>
</source>
</evidence>
<sequence length="533" mass="59591" checksum="19C90231AD0EB547" modified="1991-08-01" version="1" precursor="true">
MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQLQQRGHEIVVL
APDASLYIRDGAFYTLKTYPVPFQREDVKESFVSLGHNVFENDSFLQRVIKTYKKIKKDS
AMLLSGCSHLLHNKELMASLAESSFDVMLTDPFLPCSPIVAQYLSLPTVFFLHALPCSLE
FEATQCPNPFSYVPRPLSSHSDHMTFLQRVKNMLIAFSQNFLCDVVYSPYATLASEFLQR
EVTVQDLLSSASVWLFRSDFVKDYPRPIMPNMVFVGGINCLHQNPLSQEFEAYINASGEH
GIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDL
LGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTS
EDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHD
LTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>